Original filing text · Part II

Item 8 — Financial Statements and Supplementary Data

Angiodynamics, Inc. · 10-K · FY 2026 · Period ended May 31, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

Financial statements and supplementary data required by Part II, Item 8 are included in Part IV of this report and indexed under Item 15 (a) (1) and (2) of this report, and are incorporated by reference into this Item 8.